Tag Archives: St John
Phase II Study of Sutent ® Results Out
As published in the February 1, 2008 issue of the Journal of Clinical Oncology, a Phase II study of Sutent (sunitinib) has shown significant activity in certain cancers. Specifically, researchers found that some advanced, non-small cell lung cancers (NSCLC) that have been previously treated responded to the medication. According to the company’s website, Stutent is [...]
